A Study of Atezolizumab in Combination With Epacadostat in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma

Stopped Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.

Conditions

• NSCLC (Non-small Cell Lung Carcinoma)
• UC (Urothelial Cancer)

Interventions

• DRUG: Epacadostat
• DRUG: Atezolizumab

Sponsor

Incyte Corporation

Collaborators

• [object Object]
• [object Object]